Woodrow Wilson International Center for Scholars

Devil's Deal?

The Woodrow Wilson International Center's Eleonore Pauwels and Jim Dratwa examine personalized medicine as a sort of Faustian bargain.

NEW YORK (GenomeWeb News) – Synthetic biology has been a fast-growing field over the past four years, with more than three times as many companies operating in this area in 2013 as there were in 2009, according to analysis from the Woodrow Wilson International Center for Scholars.

NEW YORK (GenomeWeb News) – Despite steps by the US government to address recommendations from a presidential bioethics commission on synthetic biology research and development, the federal government has not fully addressed any of those recommendations, which were made in a 2010 report, the Wood

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.